PLK1 and Cyclin-dependent kinases regulatory subunit 2 (CKS2) can drive mitosis and cell cycle progression in tumor cells through deubiquitination [81], suggesting that OTUD6A is a potential therapeutic target for cancer. Here, OTUD6A is linked to neoplasm.